These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 17049771)

  • 1. A novel texture-probe for the simultaneous and real-time measurement of swelling and erosion rates of matrix tablets.
    Nazzal S; Nazzal M; El-Malah Y
    Int J Pharm; 2007 Feb; 330(1-2):195-8. PubMed ID: 17049771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrophilic matrices: application of Placket-Burman screening design to model the effect of POLYOX-carbopol blends on drug release.
    El-Malah Y; Nazzal S
    Int J Pharm; 2006 Feb; 309(1-2):163-70. PubMed ID: 16413978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Swelling and polymer erosion for poly(ethylene oxide) tablets of different molecular weights polydispersities.
    Körner A; Larsson A; Andersson A; Piculell L
    J Pharm Sci; 2010 Mar; 99(3):1225-38. PubMed ID: 19718760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous quantification of drug release and erosion from hypromellose hydrophilic matrices.
    Ghori MU; Ginting G; Smith AM; Conway BR
    Int J Pharm; 2014 Apr; 465(1-2):405-12. PubMed ID: 24560637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new approach combining different MRI methods to provide detailed view on swelling dynamics of xanthan tablets influencing drug release at different pH and ionic strength.
    Mikac U; Sepe A; Kristl J; Baumgartner S
    J Control Release; 2010 Aug; 145(3):247-56. PubMed ID: 20417675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of ethanol on swelling and release behaviors of Carbopol(®)-based tablets.
    Rahim SA; Al-Ghazawi M; Al-Zoubi N
    Pharm Dev Technol; 2013; 18(5):1089-100. PubMed ID: 22775444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of macromolecular changes and drug release from hydrophilic matrix systems.
    Jamzad S; Tutunji L; Fassihi R
    Int J Pharm; 2005 Mar; 292(1-2):75-85. PubMed ID: 15725555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graft copolymers of ethyl methacrylate on waxy maize starch derivatives as novel excipients for matrix tablets: drug release and fronts movement kinetics.
    Marinich JA; Ferrero C; Jiménez-Castellanos MR
    Eur J Pharm Biopharm; 2012 Apr; 80(3):674-81. PubMed ID: 22210473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Swelling and erosion of pectin matrix tablets and their impact on drug release behavior.
    Sriamornsak P; Thirawong N; Weerapol Y; Nunthanid J; Sungthongjeen S
    Eur J Pharm Biopharm; 2007 Aug; 67(1):211-9. PubMed ID: 17267193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New release cell for NMR microimaging of tablets. Swelling and erosion of poly(ethylene oxide).
    Abrahmsén-Alami S; Körner A; Nilsson I; Larsson A
    Int J Pharm; 2007 Sep; 342(1-2):105-14. PubMed ID: 17580107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D; Zheng W; Coots LB; McGinity JW
    Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of dissolution characteristics of polymeric and wax granulations of theophylline and their tablets.
    Uhumwangho MU; Okor RS
    Pak J Pharm Sci; 2008 Jul; 21(3):230-6. PubMed ID: 18614417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of diltiazem hydrochloride from hydrophilic matrices of polyethylene oxide and carbopol.
    Varma M; Singla AK; Dhawan S
    Drug Dev Ind Pharm; 2004 May; 30(5):545-53. PubMed ID: 15244090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring of swelling of hydrophilic polymer matrix tablets by ultrasound techniques.
    Leskinen JT; Hakulinen MA; Kuosmanen M; Ketolainen J; Abrahmsén-Alami S; Lappalainen R
    Int J Pharm; 2011 Feb; 404(1-2):142-7. PubMed ID: 21094229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of sodium dodecyl sulfate on swelling, erosion and release behavior of HPMC matrix tablets containing a poorly water-soluble drug.
    Zeng A; Yuan B; Fu Q; Wang C; Zhao G
    Pharm Dev Technol; 2009; 14(5):499-505. PubMed ID: 19743948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of delayed release tablet dosage forms by compression coating: effect of coating material on theophylline release.
    El-Malah Y; Nazzal S
    Pharm Dev Technol; 2010 Jun; 15(3):305-10. PubMed ID: 22716471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of characteristics of gel extrusion module (GEM) tablet formulation and drug dissolution rate.
    Juang RH; Storey D
    J Control Release; 2003 May; 89(3):375-85. PubMed ID: 12737840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous probing of swelling, erosion and dissolution by NMR-microimaging--effect of solubility of additives on HPMC matrix tablets.
    Tajarobi F; Abrahmsén-Alami S; Carlsson AS; Larsson A
    Eur J Pharm Sci; 2009 May; 37(2):89-97. PubMed ID: 19429415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissolution kinetics and physical characterization of three-layered tablet with poly(ethylene oxide) core matrix capped by Carbopol.
    Hong SI; Oh SY
    Int J Pharm; 2008 May; 356(1-2):121-9. PubMed ID: 18272308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.